| Title |
Pharmacological interventions for smoking cessation: an overview and network meta‐analysis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, May 2013
|
| DOI | 10.1002/14651858.cd009329.pub2 |
| Pubmed ID | |
| Authors |
Kate Cahill, Sarah Stevens, Rafael Perera, Tim Lancaster |
| Abstract |
Smoking is the leading preventable cause of illness and premature death worldwide. Some medications have been proven to help people to quit, with three licensed for this purpose in Europe and the USA: nicotine replacement therapy (NRT), bupropion, and varenicline. Cytisine (a treatment pharmacologically similar to varenicline) is also licensed for use in Russia and some of the former socialist economy countries. Other therapies, including nortriptyline, have also been tested for effectiveness. |
X Demographics
The data shown below were collected from the profiles of 61 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 7 | 11% |
| United Kingdom | 5 | 8% |
| United States | 3 | 5% |
| Australia | 2 | 3% |
| Korea, Republic of | 2 | 3% |
| India | 1 | 2% |
| Czechia | 1 | 2% |
| Nigeria | 1 | 2% |
| Mexico | 1 | 2% |
| Other | 2 | 3% |
| Unknown | 36 | 59% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 43 | 70% |
| Practitioners (doctors, other healthcare professionals) | 10 | 16% |
| Scientists | 7 | 11% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,100 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 5 | <1% |
| Canada | 3 | <1% |
| Netherlands | 2 | <1% |
| Brazil | 2 | <1% |
| France | 1 | <1% |
| Switzerland | 1 | <1% |
| Norway | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 1084 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 149 | 14% |
| Student > Bachelor | 142 | 13% |
| Researcher | 119 | 11% |
| Student > Doctoral Student | 94 | 9% |
| Student > Ph. D. Student | 93 | 8% |
| Other | 202 | 18% |
| Unknown | 301 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 404 | 37% |
| Nursing and Health Professions | 68 | 6% |
| Psychology | 68 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 43 | 4% |
| Social Sciences | 35 | 3% |
| Other | 138 | 13% |
| Unknown | 344 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 262. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2023.
All research outputs
#140,092
of 25,576,801 outputs
Outputs from Cochrane database of systematic reviews
#257
of 13,155 outputs
Outputs of similar age
#868
of 207,449 outputs
Outputs of similar age from Cochrane database of systematic reviews
#8
of 286 outputs
Altmetric has tracked 25,576,801 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,155 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,449 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 286 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.